SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-19-043753
Filing Date
2019-08-02
Accepted
2019-08-05 08:21:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D a19-16512_1sc13d.htm SC 13D 81278
  Complete submission text file 0001104659-19-043753.txt   82765
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89598 | Film No.: 19997618
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 HUNTINGTON AVENUE BOSTON MA 02115
Business Address 177 HUNTINGTON AVENUE BOSTON MA 02115 774-289-9333
NEUROBO PHARMACEUTICALS, INC. (Filed by) CIK: 0001784036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D